Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Curatis Logo
Curatis Growth Score
94
CB Rank
62910
Heat Score
83
Curatis is a pharmaceutical company that acquires, licenses, distributes, and promotes medicines.
Founded
obfuscation
PublicPost-IPO Equity Liestal, Basel-Landschaft, Switzerland1-10 curatis.com
Biopharma
Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Wholesale
Overview

Curatis
Total Funding
obfuscation
Growth Score
94
Heat Score
83

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score94
1 pts
in past quarter
Heat Score 83
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Curatis

CB Rank
62910
Curatis is a pharmaceutical company that acquires, licenses, distributes, and promotes medicines.
Founded
obfuscation
PublicPost-IPO Equity Liestal, Basel-Landschaft, Switzerland1-10 curatis.com
Biopharma
Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Wholesale

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Curatis Holding AG
Also Known As Kinarus Therapeutics Holding
Operating Status Active
Stock Symbol  SWX:CURN
Company Type For Profit
Founders  Alexander Bausch
About the Company
Curatis is a pharmaceutical company that acquires, licenses, distributes, and promotes medicines.
Phone Number +41 61 927 8777
Contact Email info@curatis.com
Predictions & Insights

Growth Insight

See this Growth Insight
Curatis is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Distribution Business for Orphan and Specialty Care Medicines
Curatis acquires, licenses, distributes, and promotes medicines for orphan and specialty diseases in Switzerland, holding exclusive distribution rights for over 40 products.
KIN001
A combination therapy consisting of pamapimod and pioglitazone, targeting viral, respiratory, and ophthalmic diseases by leveraging anti-inflammatory, anti-fibrotic, and antiviral activities.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
Yorkville Advisors Logo
Yorkville Advisors
Yes
Post-IPO Equity - Curatis Logo
Post-IPO Equity - Curatis
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 6 Board Members and Advisors 4 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,059
1,825.45%
 in past month

IT Spend

$104KThis year, Curatis is projected to spend $104K on IT, according to Aberdeen.

Active Website Tech Count

8Curatis is actively using 8 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

5The intellectual property of Curatis includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Curatis has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Curatis's headquarters? Curatis is located in Liestal, Basel-Landschaft, Switzerland.Who invested in Curatis? Curatis is funded by Yorkville Advisors.When was the last funding round for Curatis? Curatis closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Curatis's competitors? Alternatives and possible competitors to Curatis may include Sanofi, Catalyst Pharmaceuticals, and  Biogen.How much funding has Curatis raised to date? Curatis has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|